ID   TAP1_RAT                Reviewed;         725 AA.
AC   P36370;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   24-JUL-2024, entry version 174.
DE   RecName: Full=Antigen peptide transporter 1;
DE            Short=APT1;
DE            EC=7.4.2.14 {ECO:0000305|PubMed:17018292};
DE   AltName: Full=ATP-binding cassette sub-family B member 2;
DE   AltName: Full=Peptide transporter TAP1;
GN   Name=Tap1; Synonyms=Abcb2, Mtp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1979660; DOI=10.1038/348738a0;
RA   Deverson E.V., Gow I.R., Coadwell W.J., Monaco J.J., Butcher G.W.,
RA   Howard J.C.;
RT   "MHC class II region encoding proteins related to the multidrug resistance
RT   family of transmembrane transporters.";
RL   Nature 348:738-741(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BDIX; TISSUE=Lymphocyte;
RA   Deverson E.V.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 465-725 IN COMPLEX WITH ATP AND
RP   MAGNESIUM, COFACTOR, DOMAIN, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS
RP   OF 621-SER-GLY-622; ASP-645; ASP-651 AND GLN-678.
RX   PubMed=17018292; DOI=10.1016/j.molcel.2006.07.034;
RA   Procko E., Ferrin-O'Connell I., Ng S.L., Gaudet R.;
RT   "Distinct structural and functional properties of the ATPase sites in an
RT   asymmetric ABC transporter.";
RL   Mol. Cell 24:51-62(2006).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 465-725 IN COMPLEX WITH ATP AND
RP   MAGNESIUM, COFACTOR, AND MUTAGENESIS OF ASP-251.
RX   PubMed=25377891; DOI=10.1038/ncomms6419;
RA   Grossmann N., Vakkasoglu A.S., Hulpke S., Abele R., Gaudet R., Tampe R.;
RT   "Mechanistic determinants of the directionality and energetics of active
RT   export by a heterodimeric ABC transporter.";
RL   Nat. Commun. 5:5419-5419(2014).
CC   -!- FUNCTION: ABC transporter associated with antigen processing
CC       (PubMed:17018292). In complex with TAP2 mediates unidirectional
CC       translocation of peptide antigens from cytosol to endoplasmic reticulum
CC       (ER) for loading onto MHC class I (MHCI) molecules (By similarity).
CC       Uses the chemical energy of ATP to export peptides against the
CC       concentration gradient (By similarity). During the transport cycle
CC       alternates between 'inward-facing' state with peptide binding site
CC       facing the cytosol to 'outward-facing' state with peptide binding site
CC       facing the ER lumen. Peptide antigen binding to ATP-loaded TAP1-TAP2
CC       induces a switch to hydrolysis-competent 'outward-facing' conformation
CC       ready for peptide loading onto nascent MHCI molecules. Subsequently ATP
CC       hydrolysis resets the transporter to the 'inward facing' state for a
CC       new cycle (By similarity). As a component of the peptide loading
CC       complex (PLC), acts as a molecular scaffold essential for peptide-MHCI
CC       assembly and antigen presentation (By similarity).
CC       {ECO:0000250|UniProtKB:Q03518, ECO:0000269|PubMed:17018292}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a peptide antigen(in) + ATP + H2O = a peptide antigen(out) +
CC         ADP + H(+) + phosphate; Xref=Rhea:RHEA:65972, Rhea:RHEA-COMP:16941,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:166823, ChEBI:CHEBI:456216;
CC         EC=7.4.2.14; Evidence={ECO:0000305|PubMed:17018292};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65973;
CC         Evidence={ECO:0000305|PubMed:17018292};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:17018292, ECO:0000269|PubMed:25377891};
CC   -!- SUBUNIT: Heterodimer of TAP1 and TAP2 (TAP1-TAP2). A component of the
CC       peptide loading complex (PLC), interacts via TAPBP with MHCI
CC       heterodimer; this interaction mediates peptide-MHCI assembly. Interacts
CC       with PSMB5 and PSMB8. {ECO:0000250|UniProtKB:Q03518}.
CC   -!- INTERACTION:
CC       P36370; Q99JC6: Tapbp; NbExp=2; IntAct=EBI-11303917, EBI-11304538;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q03518}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=The transmembrane segments seem to form a pore in
CC       the membrane.
CC   -!- DOMAIN: The peptide-binding site is shared between the cytoplasmic
CC       loops of TAP1 and TAP2. {ECO:0000250|UniProtKB:Q03518}.
CC   -!- DOMAIN: The nucleotide-binding domain (NBD) mediates ATP hydrolysis
CC       coupled to peptide translocation. Two ATP molecules are accommodated at
CC       distinct nucleotide binding sites (NBS) at TAP1-TAP2 dimer interface.
CC       Each NBS is formed by Walker A (GxxGxGKST) and Q-loop motifs from NBD
CC       of one subunit, while the NBD from the second subunit completes the
CC       active site by contributing the C loop motif (LSGGQ). Each ATP molecule
CC       is coordinated via the beta- and gamma-phosphates to a Mg2+ ion, which
CC       is necessary for ATP hydrolysis. {ECO:0000269|PubMed:17018292}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCB family.
CC       MHC peptide exporter (TC 3.A.1.209) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA40742.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57523; CAA40742.1; ALT_INIT; mRNA.
DR   EMBL; Y10231; CAA71280.1; -; mRNA.
DR   PIR; S13426; S13426.
DR   PDB; 2IXE; X-ray; 2.00 A; A/D=465-725.
DR   PDB; 2IXF; X-ray; 2.00 A; A/B/C/D=465-725.
DR   PDB; 2IXG; X-ray; 2.70 A; A=465-725.
DR   PDB; 4K8O; X-ray; 2.65 A; A=465-725.
DR   PDBsum; 2IXE; -.
DR   PDBsum; 2IXF; -.
DR   PDBsum; 2IXG; -.
DR   PDBsum; 4K8O; -.
DR   AlphaFoldDB; P36370; -.
DR   SMR; P36370; -.
DR   IntAct; P36370; 3.
DR   STRING; 10116.ENSRNOP00000000529; -.
DR   iPTMnet; P36370; -.
DR   PhosphoSitePlus; P36370; -.
DR   jPOST; P36370; -.
DR   PaxDb; 10116-ENSRNOP00000000529; -.
DR   UCSC; RGD:3817; rat.
DR   AGR; RGD:3817; -.
DR   RGD; 3817; Tap1.
DR   eggNOG; KOG0058; Eukaryota.
DR   InParanoid; P36370; -.
DR   PhylomeDB; P36370; -.
DR   BRENDA; 7.4.2.14; 5301.
DR   Reactome; R-RNO-1236974; ER-Phagosome pathway.
DR   Reactome; R-RNO-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   EvolutionaryTrace; P36370; -.
DR   PRO; PR:P36370; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0042824; C:MHC class I peptide loading complex; IDA:UniProtKB.
DR   GO; GO:0042825; C:TAP complex; IDA:UniProtKB.
DR   GO; GO:0015433; F:ABC-type peptide antigen transporter activity; ISO:RGD.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042288; F:MHC class I protein binding; IDA:UniProtKB.
DR   GO; GO:0023029; F:MHC class Ib protein binding; ISO:RGD.
DR   GO; GO:0000166; F:nucleotide binding; IDA:RGD.
DR   GO; GO:0042605; F:peptide antigen binding; ISO:RGD.
DR   GO; GO:1904680; F:peptide transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0046978; F:TAP1 binding; IPI:UniProtKB.
DR   GO; GO:0046979; F:TAP2 binding; IPI:UniProtKB.
DR   GO; GO:0046980; F:tapasin binding; IDA:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; ISO:RGD.
DR   GO; GO:0046967; P:cytosol to endoplasmic reticulum transport; ISO:RGD.
DR   GO; GO:0006952; P:defense response; ISO:RGD.
DR   GO; GO:0046968; P:peptide antigen transport; TAS:RGD.
DR   GO; GO:0015833; P:peptide transport; IMP:RGD.
DR   GO; GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IMP:RGD.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR013305; ABC_Tap-like.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR039421; Type_1_exporter.
DR   NCBIfam; TIGR00958; 3a01208; 1.
DR   PANTHER; PTHR43394; ATP-DEPENDENT PERMEASE MDL1, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR43394:SF15; TRANSPORTER 1, ATP BINDING CASSETTE SUBFAMILY B MEMBER; 1.
DR   Pfam; PF00664; ABC_membrane; 1.
DR   Pfam; PF00005; ABC_tran; 1.
DR   PIRSF; PIRSF002773; ABC_prm/ATPase_B; 1.
DR   PRINTS; PR01896; TAP1PROTEIN.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50929; ABC_TM1F; 1.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; ATP-binding; Endoplasmic reticulum;
KW   Immunity; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Peptide transport; Protein transport; Reference proteome; Translocase;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..725
FT                   /note="Antigen peptide transporter 1"
FT                   /id="PRO_0000093328"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..29
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        30..38
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        39..60
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        61..67
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..88
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        89..110
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        111..131
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        132..163
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        164..184
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        185..204
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        205..225
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        226..275
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        276..296
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        297..305
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        306..326
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        327..395
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        396..416
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        417..420
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        421..441
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        442..725
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          164..447
FT                   /note="ABC transmembrane type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          480..719
FT                   /note="ABC transporter"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   REGION          352..397
FT                   /note="Part of the peptide-binding site"
FT                   /evidence="ECO:0000250|UniProtKB:Q03518"
FT   REGION          430..464
FT                   /note="Part of the peptide-binding site"
FT                   /evidence="ECO:0000250|UniProtKB:Q03518"
FT   BINDING         515..523
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434,
FT                   ECO:0000269|PubMed:17018292, ECO:0007744|PDB:2IXE,
FT                   ECO:0007744|PDB:2IXF, ECO:0007744|PDB:2IXG,
FT                   ECO:0007744|PDB:4K8O"
FT   BINDING         522
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:17018292,
FT                   ECO:0000269|PubMed:25377891, ECO:0007744|PDB:2IXE,
FT                   ECO:0007744|PDB:2IXF, ECO:0007744|PDB:4K8O"
FT   BINDING         618..624
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:17018292,
FT                   ECO:0000269|PubMed:25377891, ECO:0007744|PDB:2IXE,
FT                   ECO:0007744|PDB:2IXF, ECO:0007744|PDB:4K8O"
FT   BINDING         678
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:17018292,
FT                   ECO:0000269|PubMed:25377891, ECO:0007744|PDB:2IXE,
FT                   ECO:0007744|PDB:2IXG, ECO:0007744|PDB:4K8O"
FT   SITE            17
FT                   /note="Inter-subunit salt bridge with TAPBP"
FT                   /evidence="ECO:0000250|UniProtKB:Q03518"
FT   MUTAGEN         621..622
FT                   /note="SG->AV: Complete loss of ATPase activity; when
FT                   associated with N-645. Impairs peptide loading onto MHCI."
FT                   /evidence="ECO:0000269|PubMed:17018292"
FT   MUTAGEN         645
FT                   /note="D->E: Increases ATPase activity by 8-fold; when
FT                   associated with H-678."
FT                   /evidence="ECO:0000269|PubMed:17018292"
FT   MUTAGEN         645
FT                   /note="D->N: Complete loss of ATPase activity; when
FT                   associated with A-621 and V-622."
FT                   /evidence="ECO:0000269|PubMed:17018292"
FT   MUTAGEN         645
FT                   /note="D->Q: Impairs ATPase activity; when associated with
FT                   H-678."
FT                   /evidence="ECO:0000269|PubMed:17018292"
FT   MUTAGEN         651
FT                   /note="D->A,N: Decreases ATP-driven nucleotide binding
FT                   domain (NBD) dimerization."
FT                   /evidence="ECO:0000269|PubMed:25377891"
FT   MUTAGEN         678
FT                   /note="Q->H: Increases ATPase activity by 8-fold; when
FT                   associated with E-645. Impairs ATPase activity; when
FT                   associated with Q-645."
FT                   /evidence="ECO:0000269|PubMed:17018292"
FT   TURN            466..469
FT                   /evidence="ECO:0007829|PDB:2IXF"
FT   STRAND          480..487
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          498..505
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          510..514
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           521..528
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          535..541
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           546..548
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           551..557
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          558..561
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          569..571
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           572..577
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           586..595
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           599..604
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           608..610
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           615..617
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           622..634
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          639..645
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   TURN            646..649
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           652..664
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   TURN            666..670
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          671..676
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           680..683
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          687..693
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   STRAND          696..701
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           703..709
FT                   /evidence="ECO:0007829|PDB:2IXE"
FT   HELIX           712..718
FT                   /evidence="ECO:0007829|PDB:2IXE"
SQ   SEQUENCE   725 AA;  79150 MW;  3FA7215D0AC22EE0 CRC64;
     MAAHAWPTAA LLLLLVDWLL LRPVLPGIFS LLVPEVPLLR VWAVGLSRWA ILGLGVRGVL
     GVTAGARGWL AALQPLVAAL GLALPGLASF RKLSAWGALR EGDNAGLLHW NSRLDAFVLS
     YVAALPAAAL WHKLGGFWAP SGHKGAGDML CRMLGFLDSK KGRLHLVLVL LILSCLGEMA
     IPFFTGRITD WILQDKTAPS FARNMWLMCI LTIASTVLEF AGDGIYNITM GHMHSRVHGE
     VFRAVLHQET GFFLKNPTGS ITSRVTEDTS NVCESISDKL NLFLWYLGRG LCLLAFMIWG
     SFYLTVVTLL SLPLLFLLPR RLGKVYQSLA VKVQESLAKS TQVALEALSA MPTVRSFANE
     EGEAQKFRQK LEEMKPLNKK EALAYVTEVW TMSVSGMLLK VGILYLGGQL VVRGAVSSGN
     LVSFVLYQLQ FTRAVEVLLS IYPSMQKSVG ASEKIFEYLD RTPCSPLSGS LAPLNMKGLV
     KFQDVSFAYP NHPNVQVLQG LTFTLYPGKV TALVGPNGSG KSTVAALLQN LYQPTGGKVL
     LDGEPLVQYD HHYLHTQVAA VGQEPLLFGR SFRENIAYGL TRTPTMEEIT AVAMESGAHD
     FISGFPQGYD TEVGETGNQL SGGQRQAVAL ARALIRKPRL LILDDATSAL DAGNQLRVQR
     LLYESPEWAS RTVLLITQQL SLAERAHHIL FLKEGSVCEQ GTHLQLMERG GCYRSMVEAL
     AAPSD
//
